515 related articles for article (PubMed ID: 23880002)
1. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
2. Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.
Rais G; Raissouni S; Aitelhaj M; Rais F; Naciri S; Khoyaali S; Abahssain H; Bensouda Y; Khannoussi B; Mrabti H; Errihani H
BMC Womens Health; 2012 Oct; 12():35. PubMed ID: 23039971
[TBL] [Abstract][Full Text] [Related]
3. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase-polymerase chain reaction.
Greenberg R; Schwartz I; Skornick Y; Kaplan O
Breast Cancer Res; 2003; 5(3):R71-6. PubMed ID: 12793903
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Node-Positive Disease in Estrogen Receptor-Positive Breast Cancer Patients.
Gallagher J; Elleson KM; Englander K; Chintapally N; Sun W; Whiting J; Laronga C; Lee MC
J Surg Res; 2024 Mar; 295():327-331. PubMed ID: 38061237
[TBL] [Abstract][Full Text] [Related]
5. Solitary pancreatic lymph node metastasis from carcinoma of the breast: case report.
Corrado G; Garganese G; Fuoco G; Carbone A; Scambia G; Ferrandina G
Diagn Pathol; 2010 May; 5():29. PubMed ID: 20478044
[TBL] [Abstract][Full Text] [Related]
6. Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.
Dignam JJ; Dukic V; Anderson SJ; Mamounas EP; Wickerham DL; Wolmark N
Breast Cancer Res Treat; 2009 Aug; 116(3):595-602. PubMed ID: 18830816
[TBL] [Abstract][Full Text] [Related]
7. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
Abbott DE; Brouquet A; Mittendorf EA; Andreou A; Meric-Bernstam F; Valero V; Green MC; Kuerer HM; Curley SA; Abdalla EK; Hunt KK; Vauthey JN
Surgery; 2012 May; 151(5):710-6. PubMed ID: 22285778
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
[TBL] [Abstract][Full Text] [Related]
9. Identifying accessible prognostic factors for breast cancer relapse: a case-study on 405 histologically confirmed node-negative patients.
Zemni I; Ghalleb M; Jbir I; Slimane M; Ben Hassouna J; Ben Dhieb T; Bouzaiene H; Rahal K
World J Surg Oncol; 2017 Nov; 15(1):206. PubMed ID: 29169398
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
11. A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients.
Xie F; Yang H; Wang S; Zhou B; Tong F; Yang D; Zhang J
Sensors (Basel); 2012; 12(7):9936-50. PubMed ID: 23012578
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.
Dogan I; Aydin E; Khanmammadov N; Paksoy N; Ferhatoğlu F; Ak N; Emiroglu S; Ibis K; Onder S; Tukenmez M; Cabioglu N; Kucucuk S; Muslumanoğlu M; Ozmen V; Saip P; Igci A; Aydiner A
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14833-14841. PubMed ID: 37594533
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract][Full Text] [Related]
14. Are breast cancer molecular classes predictive of survival in patients with long follow-up?
Pracella D; Bonin S; Barbazza R; Sapino A; Castellano I; Sulfaro S; Stanta G
Dis Markers; 2013; 35(6):595-605. PubMed ID: 24288429
[TBL] [Abstract][Full Text] [Related]
15. Primary ectopic axillary breast cancer: a case series.
Sghaier S; GHalleb M; Marghli I; Bouida A; Ben Hassouna J; Chargui R; Rahal K
J Med Case Rep; 2021 Jul; 15(1):412. PubMed ID: 34330331
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Retraction Clefts in Chinese Invasive Breast Cancer Patients.
Huang L; Li Y; Du J; Li H; Lu M; Wang Y; Zhou W; Wang W; Wu H
Pathol Oncol Res; 2021; 27():1609743. PubMed ID: 34257612
[TBL] [Abstract][Full Text] [Related]
17. Metaplastic breast cancer with a unique presentation and complete response to chemotherapy: a case report.
Nahhat F; Doyya M; Zabad K; Ksiri H
BMC Womens Health; 2024 May; 24(1):285. PubMed ID: 38734591
[TBL] [Abstract][Full Text] [Related]
18. Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis.
Kotepui K; Kotepui M; Majima HJ; Tangpong J
BMC Cancer; 2023 Oct; 23(1):1003. PubMed ID: 37858101
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status.
Amar S; McCullough AE; Tan W; Geiger XJ; Boughey JC; McNeil RB; Coppola KE; McLaughlin SA; Palmieri FM; Perez EA
Oncologist; 2010; 15(10):1043-9. PubMed ID: 20930097
[TBL] [Abstract][Full Text] [Related]
20. The Bcl-2 protein: a prognostic indicator strongly related to ER and PR in breast cancer.
Bilalović N; Vranić S; Hasanagić S; Basić H; Tatarević A; Beslija S; Selak I
Bosn J Basic Med Sci; 2004 Oct; 4(4):5-12. PubMed ID: 15628988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
